NHLBI Progenitor Cell Biology Consortium (PCBC)

The Progenitor Cell Biology Consortium (PCBC) of the National Heart, Lung, and Blood Institute (NHLBI) performed comprehensive experimental and genomic analyses of iPSC and hESC lines from different laboratories derived using a variety of reprogramming methods.  Culture systems for the cell lines were harmonized. Resulting data are publicly available through Synapse.  

Lehanna Sanders, a graduate student in the Hatzopoulos Hub Site 11 has initiated this PCBC Blog. Other team memebers include Nicole Stone (Srivastava Hub Site 15) and Kaytlyn  Gerbin (Charles Murray's Lab - Morrisey Hub Site 14). To join the team, contact Ling Tang (ltang@epi.umaryland.edu) or Andrea Lefever (alefever@epi.umaryland.edu) for permission to post. For blog charter click here. 

The Stanford Cardiovascular Institute, Wu Hub Site 04, hosted a Cardiovascular Tissue Engineering Symposium and Drug Discovery Conference on March 29, 2016. Experts in drug discovery discussed advances in research and technology.
 

Topics covered included:

PCBC Jump Start Award Program

Purpose:

To provide the PCBC with a mechanism to quickly award small grants to junior faculty (less than 5 years from their appointment to Assistant Professor), research associates, fellows, postdocs, and graduate students to support a well-defined specific aim. The aim should involve at least one of the following, with priority given to proposals that incorporate two: